Repositioning Candidate Details
| Candidate ID: | R1273 |
| Source ID: | DB09260 |
| Source Type: | approved; investigational |
| Compound Type: | small molecule |
| Compound Name: | Parnaparin |
| Synonyms: | Parnaparin sodium |
| Molecular Formula: | -- |
| SMILES: | -- |
| DrugBank Description: | Parnaparin is an heparin of low molecular weight with antithrombotic effects. |
| CAS Number: | 9005-49-6 |
| Molecular Weight: | |
| DrugBank Indication: | Used in the prevention and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I08 | 114 | Cardiovascular system disease | A disease of anatomical entity which occurs in the blood, heart, blood vessels or the lymphatic system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells or lymph to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis. http://en.wikipedia.org/wiki/Circulatory_system | disease of anatomical entity | Details |